Tenaya Therapeutics, South San Francisco (United States of America)
Follow
Contributor content
Presentation
PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathy
